Last Updated: 31-07-2025 | Format: PDF | Report ID:20233 | Author: Ankit
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $11,500 Million |
| What is the projected market size by 2035? | $23,400 Million |
| What is the market CAGR from 2025 to 2035? | 7.4% |
| Which region dominates the market? | US (75%) |
| Which product/service type dominates the market? | PCR-Based Diagnostics (45%) |
| Which application leads the market? | Oncology (38%) |
| Who are the major buyers? | Hospitals (40%), Diagnostic Laboratories (28%) |
| What are the key market growth drivers? | Rising prevalence of chronic and genetic diseases: The increased incidence of cancer; Rapid advancements in diagnostic technology: The integration of next-generation sequencing and digital PCR is enhancing the speed and accuracy of DNA diagnostics |
| What are the major market challenges? | Data privacy and security concerns: The explosion of sensitive genetic data collection has heightened the risk of breaches; High cost of advanced diagnostics: Despite technological progress |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? | Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Hologic Inc., Illumina Inc., Qiagen, Agilent Technologies, Danaher Corporation, Becton Dickinson & Company, Cepheid, Genomic Health, Myriad Genetics, Luminex Corporation, Siemens Healthineers |
North America Oligonucleotide CDMO Market: by Type (Custom Oligonucleotides, Pre-designed Oligonucleotides, DNA Oligonucleotides, RNA Oligonucleotides, Modified Oligonucleotides, Others), Application (Diagnostics, Research, Therapeutics, Forensics, Others), Distribution Channels (Direct Tender, Online Sales, Distributors, Retail Sales, Others), Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, Enzymatic Synthesis, PCR-based Synthesis, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Biosimilars Treatment Market: by Type (Monoclonal Antibodies, Recombinant Hormones, Fusion Proteins, Immunomodulators, Insulins, Erythropoietin), Application (Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Infectious Diseases, Other Applications), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Drug Stores, Others), Technology (Recombinant DNA Technology, Monoclonal Antibody Technology, Genomics, Proteomics, Bioengineering, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Digital Biomarkers Market: by Type (Wearable Devices, Mobile Health Apps, Biosensors, Clinical Trials Platforms, Digital Diagnostics, Passive Monitoring Systems), Application (Cardiovascular Disease, Neurodegenerative Disorders, Diabetes, Respiratory Disease, Oncology, Others), Distribution Channels (Hospitals, Clinics, Research Centers, Homecare, Pharmacies, Online), Technology (Artificial Intelligence, Internet of Things, Machine Learning, Cloud Computing, Blockchain, Data Analytics), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Wearables in Pharma & Biotech Market: by Type (Smartwatches, Fitness Trackers, Patches, Smart Clothing, Biosensors, Implantables), Application (Remote Patient Monitoring, Clinical Trials, Disease Management, Diagnostics, Fitness & Wellness, Drug Delivery), Distribution Channels (Online, Offline/Pharmacy, Direct, Distributors, Hospitals, Clinics), Technology (Bluetooth, Wi-Fi, NFC, Cellular, RFID, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025